- Home
- CTNT vs TOVX Comparison
CTNT vs TOVX Comparison
Compare CTNT & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNT
- TOVX
- Stock Information
- Founded
- CTNT 2016
- TOVX 2001
- Country
- CTNT United States
- TOVX United States
- Employees
- CTNT N/A
- TOVX N/A
- Industry
- CTNT
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- CTNT
- TOVX Health Care
- Exchange
- CTNT Nasdaq
- TOVX Nasdaq
- Market Cap
- CTNT 5.0M
- TOVX 3.6M
- IPO Year
- CTNT 2023
- TOVX 2006
- Fundamental
- Price
- CTNT $1.40
- TOVX $0.49
- Analyst Decision
- CTNT Hold
- TOVX Hold
- Analyst Count
- CTNT 1
- TOVX 1
- Target Price
- CTNT N/A
- TOVX N/A
- AVG Volume (30 Days)
- CTNT 32.8K
- TOVX 2.4M
- Earning Date
- CTNT 05-05-2025
- TOVX 05-20-2025
- Dividend Yield
- CTNT N/A
- TOVX N/A
- EPS Growth
- CTNT N/A
- TOVX N/A
- EPS
- CTNT N/A
- TOVX N/A
- Revenue
- CTNT $858,770.00
- TOVX N/A
- Revenue This Year
- CTNT N/A
- TOVX N/A
- Revenue Next Year
- CTNT $25.00
- TOVX N/A
- P/E Ratio
- CTNT N/A
- TOVX N/A
- Revenue Growth
- CTNT N/A
- TOVX N/A
- 52 Week Low
- CTNT $1.20
- TOVX $0.74
- 52 Week High
- CTNT $236.16
- TOVX $12.25
- Technical
- Relative Strength Index (RSI)
- CTNT 43.50
- TOVX 23.01
- Support Level
- CTNT $1.26
- TOVX $1.32
- Resistance Level
- CTNT $1.55
- TOVX $1.45
- Average True Range (ATR)
- CTNT 0.13
- TOVX 0.14
- MACD
- CTNT -0.01
- TOVX -0.09
- Stochastic Oscillator
- CTNT 21.31
- TOVX 0.86
About CTNT Cheetah Net Supply Chain Service Inc.
Cheetah Net Supply Chain Service Inc is a one-stop services including Warehousing, Logistics, International trading & Supply Chain Finance, Etc. It operate in single segment Logistics and warehousing services which focuses on providing freight forwarding services for clients shipping goods from the U.S. to mainland China or Hong Kong. Its services include: (i) cargo storage, (ii) freight forwarding, (iii) U.S. customs clearance, and (iv) labor services and cargo loading and unloading.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.